functional genomics
Volastra Therapeutics Inks Two New Deals to ID Biomarkers for KIF18A Inhibitor Patient Selection
The firm's new predictive biomarker-focused collaborations with Function Oncology and Tailor Bio build on a 2020 deal with Microsoft.
Bristol Myers Squibb, Medic Life Sciences Collaborate on Tumor Target Discovery
Medic will receive upfront payments and will be eligible for additional option payments, as well as future development and regulatory milestone payments.
Function Oncology Launches With $28M, Seeks to Transform Precision Cancer Therapy With CRISPR
Premium
The firm unveiled early validation data for its CRISPR-based functional genomics platform, which it hopes to commercialize as another tool doctors can use to individualize cancer care.
Leukemia Patients See Survival Benefit With Integrated Functional Drug, Molecular Testing Approach
Premium
Data presented at ASH's annual meeting showed that patients on matched drugs based on genomic sequencing and high-throughput drug testing lived longer than those who did not.
Functional Precision Medicine Firm Kiyatec Raises $18M in Series C Funding Round
The Clemson University spinout is developing live tissue-based models of cancer cells for use in predicting patients' individual drug responses.